• Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo
  Catalog No.:BS8759        Pubmed No.:33640712        PMCID:
  Details:
  Journal name:
• Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo
  Catalog No.:AP0063        Pubmed No.:33640712        PMCID:
  Details:
  Journal name:
• Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo
  Catalog No.:MB001        Pubmed No.:33640712        PMCID:
  Details:
  Journal name:
• Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo
  Catalog No.:AP0060        Pubmed No.:33640712        PMCID:
  Details:
  Journal name:
• Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo
  Catalog No.:BS6007M        Pubmed No.:33640712        PMCID:
  Details:
  Journal name:
• Salvianolic acid A inhibits tumor-associated angiogenesis by blocking GRP78 secretion
  Catalog No.:AP0063        Pubmed No.:30560355        PMCID:
  Details:
  Journal name:
• Salvianolic acid A inhibits tumor-associated angiogenesis by blocking GRP78 secretion
  Catalog No.:MB001        Pubmed No.:30560355        PMCID:
  Details:
  Journal name:
• Salvianolic acid B protects against ANIT-induced cholestatic liver injury through regulating bile acid transporters and enzymes, and NF-κB/IκB and MAPK pathways
  Catalog No.:MB001H        Pubmed No.:31098695        PMCID:
  Details:
  Journal name:
• Salvianolic acid B protects against ANIT-induced cholestatic liver injury through regulating bile acid transporters and enzymes, and NF-κB/IκB and MAPK pathways
  Catalog No.:L3012-2        Pubmed No.:31098695        PMCID:
  Details:
  Journal name:
• LncRNA linc00460 sponges miR-1224-5p to promote esophageal cancer metastatic potential and epithelial-mesenchymal transition
  Catalog No.:MB001        Pubmed No.:32534700        PMCID:
  Details:
  Journal name:
• LncRNA linc00460 sponges miR-1224-5p to promote esophageal cancer metastatic potential and epithelial-mesenchymal transition
  Catalog No.:AP0063        Pubmed No.:32534700        PMCID:
  Details:
  Journal name:
• Atorvastatin ameliorates the contractile dysfunction of the aorta induced by organ culture
  Catalog No.:BS70000        Pubmed No.:30182188        PMCID:
  Details:
  Journal name:
• Atorvastatin ameliorates the contractile dysfunction of the aorta induced by organ culture
  Catalog No.:BS2535        Pubmed No.:30182188        PMCID:
  Details:
  Journal name:
• MiR-1-5p is down-regulated in gallbladder carcinoma and suppresses cell proliferation, migration and invasion by targeting Notch2
  Catalog No.:BS13278        Pubmed No.:30497876        PMCID:
  Details:
  Journal name:
• MiR-1-5p is down-regulated in gallbladder carcinoma and suppresses cell proliferation, migration and invasion by targeting Notch2
  Catalog No.:BS10950        Pubmed No.:30497876        PMCID:
  Details:
  Journal name: